SCHEMBL30683047

SCHEMBL30683047

CC(C)(C)OC(=O)NCCC(C)(C)[C@H](C(=O)OCc1ccccc1)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.45
MALT1 Q9UDY8 1/20 0.44
IDO1 P14902 1/20 0.44
MAPT P10636 2/20 0.43
POLB P06746 1/20 0.43
MAPK1 P28482 1/20 0.43
MEN1 O00255 1/20 0.42
RECQL P46063 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
RAB9A P51151 1/20 0.42
TPSAB1 Q15661 3/20 0.41
TPSD1 Q9BZJ3 3/20 0.41
TPSG1 Q9NRR2 3/20 0.41
PDCD1 Q15116 1/20 0.41
CD274 Q9NZQ7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30683053 1.00 SYK (0.47) SYKL3MBTL1MALT1IDO1MAPT
SCHEMBL30683041 1.00 SYK (0.47) SYKL3MBTL1MALT1IDO1MAPT
SCHEMBL26932017 1.00 SYK (0.47) SYKL3MBTL1MALT1IDO1MAPT
SCHEMBL26931815 0.87 MALT1 (0.49) MALT1IDO1MEN1KMT2ATPSAB1
SCHEMBL26931811 0.87 MALT1 (0.49) MALT1IDO1MEN1KMT2ATPSAB1
SCHEMBL24838499 0.82 ALDH1A1 (0.43) L3MBTL1POLBCYP3A4CYP2D6CYP2C9
SCHEMBL26932025 0.82 ALDH1A1 (0.40) SYKL3MBTL1POLB
SCHEMBL30683055 0.82 ALDH1A1 (0.40) SYKL3MBTL1POLB
SCHEMBL26960533 0.79 SYK (0.54) SYKL3MBTL1IDO1MAPTPOLB
SCHEMBL26931772 0.79 SYK (0.54) SYKL3MBTL1IDO1MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023239645-A1 SMARCA DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-12-14 WO disclosed